par Marechal, Raphaël ;Demols, Anne ;Gay, Frederick;De Maertelaer, Viviane ;Arvanitakis, Marianna ;Hendlisz, Alain ;Van Laethem, Jean-Luc
Référence Oncology, 73, 1-2, page (41-51)
Publication Publié, 2007
Référence Oncology, 73, 1-2, page (41-51)
Publication Publié, 2007
Article révisé par les pairs
Titre: |
|
Auteur: | Marechal, Raphaël; Demols, Anne; Gay, Frederick; De Maertelaer, Viviane; Arvanitakis, Marianna; Hendlisz, Alain; Van Laethem, Jean-Luc |
Informations sur la publication: | Oncology, 73, 1-2, page (41-51) |
Statut de publication: | Publié, 2007 |
Sujet CREF: | Sciences bio-médicales et agricoles |
Mots-clés: | Gemcitabine |
Neoplasms | |
Pancreas | |
Prognosis | |
MeSH keywords: | Actuarial Analysis |
Adenocarcinoma -- drug therapy -- secondary | |
Adult | |
Aged | |
Aged, 80 and over | |
Albumins -- metabolism | |
Antimetabolites, Antineoplastic -- therapeutic use | |
Aspartate Aminotransferases -- blood | |
CA-19-9 Antigen -- blood | |
Deoxycytidine -- analogs & derivatives -- therapeutic use | |
Disease-Free Survival | |
Drug Resistance, Neoplasm | |
Female | |
Humans | |
Karnofsky Performance Status | |
Male | |
Middle Aged | |
Pancreatic Neoplasms -- drug therapy -- pathology | |
Predictive Value of Tests | |
Prognosis | |
Proportional Hazards Models | |
Retrospective Studies | |
Survival Analysis | |
Tumor Markers, Biological -- blood | |
Weight Loss | |
Note générale: | Journal Article |
Langue: | Anglais |
Identificateurs: | urn:issn:0030-2414 |
info:doi/10.1159/000120627 | |
info:pii/000120627 | |
info:scp/41549100207 | |
info:pmid/18334830 |